Technologies
PDF


WARF: P07499US

  • Assigned to WARF as biological material.

Polyclonal Antibodies Against Cardiovirus 2A, 2B, 2C, 3C, 3A, 3B and 3AB Proteins


INVENTORS -

Ann Palmenberg, Svetlana Amineva, Aleksey Aminev

The Wisconsin Alumni Research Foundation (WARF) is seeking commercial partners interested in polyclonal antibodies against several cardiovirus proteins.
OVERVIEWEncephalomyocarditis virus, a cardiovirus, causes encephalitis and myocarditis. It is a widespread problem in swine, causing sudden death and reproductive failure and potentially leading to severe economic losses for pork producers. This virus also infects exotic mammals such as elephants and llamas.
THE INVENTIONUW-Madison researchers have developed polyclonal mouse antibodies against recombinant cardiovirus proteins. The antibodies can be used for specific molecular recognition of the cardiovirus proteins in vitro or in vivo using experimental techniques such as ELISA (enzyme linked immunosorbent assay), Western assays, protein immunoprecipitation (IP) and confocal fluorescence microscopy.
APPLICATIONS
  • Studying cardiovirus proteins
  • May lead to new means of detecting, preventing and treating cardiovirus infection, including encephalomyocarditis virus infection
KEY BENEFITS
  • All reagents have been tested for efficacy.
  • Most of the antibodies react with viral precursor proteins, in addition to the mature proteins against which they were raised.
ADDITIONAL INFORMATION
For More Information About the Inventors
Related Technologies
  • For more antibodies identified by the inventors, see WARF reference numbers:
  • P07448US
  • P07500US
Publications
  • Aminev A.G., Amineva S.P. & Palmenberg A.C. 2003. Encephalomyocarditis Virus (EMCV) Proteins 2A and 3BCD Localize to Nuclei and Inhibit Cellular mRNA Transcription but not rRNA Transcription. Virus Res. 95, 59-73.
  • Aminev A.G., Amineva S.P. & Palmenberg A.C. 2003. Encephalomyocarditis Viral Protein 2A Localizes to Nucleoli and Inhibits Cap-Dependent mRNA Translation. Virus Res. 95, 45-57.
Contact Information
For current licensing status, please contact Jennifer Gottwald at jennifer@warf.org or 608-960-9854.
The WARF Advantage

Since its founding in 1925 as the patenting and licensing organization for the University of Wisconsin-Madison, WARF has been working with business and industry to transform university research into products that benefit society. WARF intellectual property managers and licensing staff members are leaders in the field of university-based technology transfer. They are familiar with the intricacies of patenting, have worked with researchers in relevant disciplines, understand industries and markets, and have negotiated innovative licensing strategies to meet the individual needs of business clients.